Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the std diagnostics market?

The market for STD diagnostics has seen significant expansion in the past few years. The growth is expected to continue, as it’s projected to increase from $9.93 billion in 2024 to $10.86 billion in 2025, representing a compound annual growth rate (CAGR) of 9.4%. This growth during the historical period is due mainly to factors such as epidemiological trends, advancements in healthcare infrastructure, developments in the pharmaceutical sector, sexual education initiatives, and demographic changes.

What will be the std diagnostics market size in the future?

Rapid expansion is anticipated in the STD diagnostics market size over the next few years, with a predicted growth to $16.21 billion in 2029 and a compound annual growth rate (CAGR) of 10.5%. Factors encouraging the growth in the forecasted period include the trend of personalized medicine, advancements in healthcare accessibility, population health initiatives, the evolution of telemedicine and digital health, and an increase in STD incidences. Key trends on the horizon within the forecast period involve progress in point-of-care testing (POCT), the advancement of home testing kits, multiplex trials, targeted marketing campaigns and outreach, initiation of pre-exposure prophylaxis (prep) programs, and climbing incidence rates.

Get your std diagnostics market report here!

https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

What main drivers are fueling expansion in the std diagnostics market?

The expanding incidence of sexually transmitted diseases (STDs) is propelling the STD diagnostics market. STDs are infections that are transmitted from a person carrying the disease to a healthy person via sexual activity. STD diagnostics facilitate the effective detection and analysis of such diseases. As per a 2022 report by the World Health Organization (WHO), an international institution of the United Nations aimed at global public health enhancement, there are over 1 million new sexually transmitted infections globally each day. Furthermore, annually, there are roughly 374 million fresh cases of 1 of 4 STDs namely, chlamydia, gonorrhea, syphilis, and trichomoniasis. Consequently, the increasing STD cases bolster the STD diagnostics market.

What key areas define the segmentation of the global std diagnostics market?

The STD diagnostics market covered in this report is segmented –

1) By Type: Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, Other Types

2) By Location Of Testing: Laboratory Testing, Point Of Care (PoC) Testing

3) By End-User: Hospitals And Clinics, Diagnostic Centers, Homecare

Subsegments:

1) By Chlamydia Testing: Nucleic Acid Amplification Tests (NAAT), Antigen Tests

2) By Syphilis Testing: Rapid Plasma Reagin (RPR) Tests, Treponemal Tests

3) By Gonorrhea Testing: Nucleic Acid Amplification Tests (NAAT), Culture Tests

4) By Herpes Simplex Virus Testing: PCR Tests, Serological Tests

5) By Human Papilloma Virus Testing: HPV DNA Tests, HPV RNA Tests

6) By Human Immunodeficiency Virus Testing: Antibody Tests, Antigen Or Antibody Tests, Nucleic Acid Tests (NAT)

7) By Chancroid Testing: Culture Tests, Nucleic Acid Tests

8) By Other Types: Various Emerging Tests

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8507&type=smp

Who are the dominant players expanding their reach in the std diagnostics market?

Major companies operating in the STD diagnostics market are Siemens AG, Abbott Laboratories, Qiagen Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., NOWDiagnostics Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMérieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics, Enzo Biochem Inc., Fujirebio Diagnostics Inc., GenePOC Inc., GenMark Diagnostics Inc., Grifols Diagnostic Solutions Inc., Hain Lifescience GmbH, InDevR Inc., Karius Inc., Luminex Corporation, Meridian Bioscience Inc., Mesa Biotech Inc., Mobidiag Oy

How are evolving market trends shaping std diagnostics Strategies?

The progression in the field of STD diagnostics is a significant trend within the STD diagnostic market. Prominent industry players are enhancing their diagnostic facilities and methods to facilitate more efficient and quicker detection of sexually transmitted diseases. For example, BD (Becton, Dickinson, and Company), a medical technology firm based in the US, introduced a fully automated infectious disease molecular diagnostics platform in May 2022. This platform, known as the BD CORTM MX/PX System, merges and automates the molecular laboratory process, from sample handling to the delivery of diagnostic test results. The initial test available on this new system is the BD CTGCTV2 molecular assay. This single test can detect the top three non-viral sexually transmitted infections: Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV).

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8507

Which regions are emerging as leaders in the std diagnostics market?

North America was the largest region in the STD diagnostics market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the STD diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Diagnostic Enzyme Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/diagnostic-enzymes-global-market-report

Molecular Diagnostics Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-global-market-report

Point-of-Care Diagnostics Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: